What You Need to Know about Prostate Cancer Screening
PSA vs PHI: What’s the Difference?
The PSA (prostate-specific antigen) test is the most common screening tool for prostate cancer. It measures the level of PSA, a protein made by the prostate, in your blood. High PSA levels can suggest prostate cancer, but they can also be caused by other conditions, like an enlarged prostate or infection.
The PHI (prostate health index) test is a more advanced tool. It combines 3 different PSA measurements to create a score that helps doctors better understand your risk of prostate cancer. PHI can reduce unnecessary biopsies by giving a clearer picture of whether elevated PSA levels are due to cancer or another condition.
When to Start Screening
Explore related topics
The role of biomarkers in prostate cancer care
Biomarkers, including some inherited gene mutations, help determine the risk, possible course, and treatment of prostate cancer.
The role of health disparities in prostate cancer outcomes
Prostate cancer outcomes can be impacted based on who you are and where you live.
Prostate cancer screening and early detection
Learn more about the latest screening options for prostate cancer, including PSA tests, and how they can help catch the disease in its earliest stages.